Tommy
bigot with fetish for footballers getting fingered
Science is awesome, ladies and gentlemen!
European regulators give Mosquirix the green light to be used on babies at risk of the mosquito-borne disease in Africa.
"The world's first malaria vaccine has received a green light from European drugs regulators who recommended it should be licensed for use in babies in Africa who are at risk of the mosquito-borne disease.
The shot, called RTS,S or Mosquirix, would be the first licensed human vaccine against a parasitic disease and could help prevent millions of cases of malaria in countries that use it.
Malaria killed an estimated 584,000 people in 2013, the vast majority of them in sub-Saharan Africa.
More than 80 percent of malaria deaths are in children under the age of five.
Global health experts have long hoped scientists would be able to develop an effective malaria vaccine, and researchers at GSK have been working on RTS,S for 30 years.
Hopes that the shot would be the final answer to wiping out malaria were dampened when trial data released in 2011 and 2012 showed it only reduced episodes of malaria in babies aged 6-12 weeks by 27 percent, and by around 46 percent in children aged 5-17 months.
EMA's recommendation is that the shot should nevertheless be licensed for use in babies in the full age range covered in the trials - from 6 weeks to 17 months"
More detail in the link Alright, so it's not 100% effective, but it's a huge step forward and will save millions of lives
European regulators give Mosquirix the green light to be used on babies at risk of the mosquito-borne disease in Africa.
"The world's first malaria vaccine has received a green light from European drugs regulators who recommended it should be licensed for use in babies in Africa who are at risk of the mosquito-borne disease.
The shot, called RTS,S or Mosquirix, would be the first licensed human vaccine against a parasitic disease and could help prevent millions of cases of malaria in countries that use it.
Malaria killed an estimated 584,000 people in 2013, the vast majority of them in sub-Saharan Africa.
More than 80 percent of malaria deaths are in children under the age of five.
Global health experts have long hoped scientists would be able to develop an effective malaria vaccine, and researchers at GSK have been working on RTS,S for 30 years.
Hopes that the shot would be the final answer to wiping out malaria were dampened when trial data released in 2011 and 2012 showed it only reduced episodes of malaria in babies aged 6-12 weeks by 27 percent, and by around 46 percent in children aged 5-17 months.
EMA's recommendation is that the shot should nevertheless be licensed for use in babies in the full age range covered in the trials - from 6 weeks to 17 months"
More detail in the link Alright, so it's not 100% effective, but it's a huge step forward and will save millions of lives